title: BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib.
authors.affiliation: Hospices Civils de Lyon, Lyon-Sud Hospital, Cytogenetics and Molecular Biology Department, Pierre Bénite, France. mael.heiblig@live.fr.|Hematology Department 1G, Hôpital de Lyon Sud, 169 chemin du grand Revoyet, 69139, Pierre Bénite, France. mael.heiblig@live.fr.
authors.forename: Heiblig
authors.initials: H
authors.lastname: Maël
authors.affiliation: CHU de Bordeaux, Hematology Laboratory, Pessac, France.
authors.forename: Bidet
authors.initials: B
authors.lastname: Audrey
authors.affiliation: Hospices Civils de Lyon, Lyon-Sud Hospital, Cytogenetics and Molecular Biology Department, Pierre Bénite, France.
authors.forename: Callet-Bauchu
authors.initials: CB
authors.lastname: Evelyne
authors.affiliation: CHU de Bordeaux, Hematology Department, Pessac, France.
authors.forename: Dumas
authors.initials: D
authors.lastname: Pierre-Yves
authors.affiliation: Hospices Civils de Lyon, Lyon-Sud Hospital, Cytogenetics and Molecular Biology Department, Pierre Bénite, France.
authors.forename: Chabane
authors.initials: C
authors.lastname: Kaddour
authors.affiliation: Hospices Civils de Lyon, Lyon-Sud Hospital, Hematology Department, Pierre Bénite, France.
authors.forename: Salles
authors.initials: S
authors.lastname: Gilles
authors.affiliation: CHU de Bordeaux, Hematology Department, Pessac, France.|Université de Bordeaux, INSERM 1035, Bordeaux, France.
authors.forename: Pigneux
authors.initials: P
authors.lastname: Arnaud
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000188:drug therapy*; D011724:Pyridazines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D007093:Imidazoles; D011724:Pyridazines; C545373:ponatinib